Patents by Inventor Harumi Minekawa
Harumi Minekawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8389221Abstract: The present invention provides oligonucleotide primers specifically hybridizing to an arbitrary nucleotide sequence designed from the nucleotide sequence of hemagglutinin of an H5 or H7 avian influenza virus, a nucleic acid amplification method using the primers, a method for diagnosis of infection with an H5 or H7 avian influenza virus by detection of nucleic acid amplification, and a kit for influenza diagnosis.Type: GrantFiled: September 14, 2011Date of Patent: March 5, 2013Assignees: Japan as represented by Director-General of National Institute of Infectious Diseases, Eiken Kagaku Kabushiki KaishaInventors: Harumi Minekawa, Toshihiro Yonekawa, Takato Odagiri
-
Publication number: 20120100527Abstract: The present invention provides oligonucleotide primers specifically hybridizing to an arbitrary nucleotide sequence designed from the nucleotide sequence of hemagglutinin of an H5 or H7 avian influenza virus, a nucleic acid amplification method using the primers, a method for diagnosis of infection with an H5 or H7 avian influenza virus by detection of nucleic acid amplification, and a kit for influenza diagnosis.Type: ApplicationFiled: September 14, 2011Publication date: April 26, 2012Applicants: JAPAN AS REP. BY NAT'L INST. OF INFECT. DISEASES, EIKEN KAGAKU KABUSHIKI KAISHAInventors: Harumi Minekawa, Tsugunori Notomi, Toshihiro Yonekawa, Norihiro Tomita, Yoko Kuzuhara, Takato Odagiri
-
Patent number: 8076080Abstract: It is intended to provide novel primers to be used in gene amplification reactions for detecting human cytokeratins (Human CK). A primer containing an oligonucleotide comprising a base sequence which is selected from among the the 270- to 1375-th regions of the base sequence represented by SEQ ID NO:1 and the regions of complementary strands thereof and represented by, for example, any of SEQ ID NOS:2 to 341 is constructed. Further, a primer containing an oligonucleotide comprising a base sequence which is selected from among the 270- to 930-th regions of the base sequence represented by SEQ ID NO:342 and the regions of complementary strands thereof and represented by, for example, any of SEQ ID NOS:343 to 434 is constructed.Type: GrantFiled: May 20, 2003Date of Patent: December 13, 2011Assignee: Sysmex CorporationInventors: Sachiyo Tada, Yasumasa Akai, Yasuyuki Imura, Shigeki Abe, Harumi Minekawa
-
Patent number: 8043813Abstract: The present invention provides oligonucleotide primers specifically hybridizing to an arbitrary nucleotide sequence designed from the nucleotide sequence of hemagglutinin of an H5 or H7 avian influenza virus, a nucleic acid amplification method using the primers, a method for diagnosis of infection with an H5 or H7 avian influenza virus by detection of nucleic acid amplification, and a kit for influenza diagnosis.Type: GrantFiled: October 26, 2005Date of Patent: October 25, 2011Assignees: Japan as represented by Director-General of National Institute of Infectious Diseases, Eiken Kagaku Kabushiki KaishaInventors: Harumi Minekawa, Tsugunori Notomi, Toshihiro Yonekawa, Norihiro Tomita, Yoko Kuzuhara, Takato Odagiri
-
Publication number: 20090317795Abstract: The present invention provides oligonucleotide primers specifically hybridizing to an arbitrary nucleotide sequence designed from the nucleotide sequence of hemagglutinin of an H5 or H7 avian influenza virus, a nucleic acid amplification method using the primers, a method for diagnosis of infection with an H5 or H7 avian influenza virus by detection of nucleic acid amplification, and a kit for influenza diagnosis.Type: ApplicationFiled: October 26, 2005Publication date: December 24, 2009Inventors: Harumi Minekawa, Tsugunori Notomi, Toshihiro Yonekawa, Norihiro Tomita, Yoko Kuzuhara, Takato Odagiri
-
Patent number: 7595163Abstract: This invention provides: a method for detecting SARS pathogenic viruses with high sensitivity and rapidity for diagnosing severe acute respiratory syndrome (SARS); an oligonucleotide primer that can specifically hybridize with any nucleotide sequence constructed based on the nucleotide sequence of RNA polymerase of the SARS coronavirus; a method for nucleic acid amplification using such primer; a method for diagnosing infection with the SARS coronavirus via detection of nucleic acid amplification; and a kit for diagnosing SARS.Type: GrantFiled: June 10, 2008Date of Patent: September 29, 2009Assignee: Eiken Kagaku Kabushiki KaishaInventors: Harumi Minekawa, Keiko Watanabe, Shinichi Kojiya
-
Patent number: 7595381Abstract: This invention provides: a method for detecting SARS pathogenic viruses with high sensitivity and rapidity for diagnosing severe acute respiratory syndrome (SARS); an oligonucleotide primer that can specifically hybridize with any nucleotide sequence constructed based on the nucleotide sequence of RNA polymerase of the SARS coronavirus; a method for nucleic acid amplification using such primer; a method for diagnosing infection with the SARS coronavirus via detection of nucleic acid amplification; and a kit for diagnosing SARS.Type: GrantFiled: June 10, 2008Date of Patent: September 29, 2009Assignee: Eiken Kagaku Kabushiki KaishaInventors: Harumi Minekawa, Keiko Watanabe, Shinichi Kojiya
-
Publication number: 20090117537Abstract: This invention provides: a method for detecting SARS pathogenic viruses with high sensitivity and rapidity for diagnosing severe acute respiratory syndrome (SARS); an oligonucleotide primer that can specifically hybridize with any nucleotide sequence constructed based on the nucleotide sequence of RNA polymerase of the SARS coronavirus; a method for nucleic acid amplification using such primer; a method for diagnosing infection with the SARS coronavirus via detection of nucleic acid amplification; and a kit for diagnosing SARS.Type: ApplicationFiled: June 10, 2008Publication date: May 7, 2009Applicant: EIKEN KAGAKU KABUSHIKI KAISHAInventors: Harumi MINEKAWA, Keiko Watanabe, Shinichi Kojiya
-
Publication number: 20090092962Abstract: This invention provides: a method for detecting SARS pathogenic viruses with high sensitivity and rapidity for diagnosing severe acute respiratory syndrome (SARS); an oligonucleotide primer that can specifically hybridize with any nucleotide sequence constructed based on the nucleotide sequence of RNA polymerase of the SARS coronavirus; a method for nucleic acid amplification using such primer; a method for diagnosing infection with the SARS coronavirus via detection of nucleic acid amplification; and a kit for diagnosing SARS.Type: ApplicationFiled: June 10, 2008Publication date: April 9, 2009Applicant: EIKEN KAGAKU KABUSHIKI KAISHAInventors: Harumi Minekawa, Keiko Watanabe, Shinichi Kojiya
-
Patent number: 7399588Abstract: This invention provides: a method for detecting SARS pathogenic viruses with high sensitivity and rapidity for diagnosing severe acute respiratory syndrome (SARS); an oligonucleotide primer that can specifically hybridize with any nucleotide sequence constructed based on the nucleotide sequence of RNA polymerase of the SARS coronavirus; a method for nucleic acid amplification using such primer; a method for diagnosing infection with the SARS coronavirus via detection of nucleic acid amplification; and a kit for diagnosing SARS.Type: GrantFiled: June 15, 2004Date of Patent: July 15, 2008Assignee: Eiken Kagaku Kabushiki KaishaInventors: Harumi Minekawa, Keiko Watanabe, Shinichi Kojiya
-
Publication number: 20070099178Abstract: This invention provides: a method for detecting SARS pathogenic viruses with high sensitivity and rapidity for diagnosing severe acute respiratory syndrome (SARS); an oligonucleotide primer that can specifically hybridize with any nucleotide sequence constructed based on the nucleotide sequence of RNA polymerase of the SARS coronavirus; a method for nucleic acid amplification using such primer; a method for diagnosing infection with the SARS coronavirus via detection of nucleic acid amplification; and a kit for diagnosing SARS.Type: ApplicationFiled: June 15, 2004Publication date: May 3, 2007Applicant: EIKEN KAGAKU KABUSHIKI KAISHAInventors: Harumi Minekawa, Keiko Watanabe, Shinichi Kojiya
-
Publication number: 20060094008Abstract: It is intended to provide novel primers to be used in gene amplification reactions for detecting human cytokeratins (Human CK). A primer containing an oligonucleotide comprising a base sequence which is selected from among the the 270- to 1375-th regions of the base sequence represented by SEQ ID NO:1 and the regions of complementary strands thereof and represented by, for example, any of SEQ ID NOS:2 to 341 is constructed. Further, a primer containing an oligonucleotide comprising a base sequence which is selected from among the 270- to 930-th regions of the base sequence represented by SEQ ID NO:342 and the regions of complementary strands thereof and represented by, for example, any of SEQ ID NOS:343 to 434 is constructed.Type: ApplicationFiled: May 20, 2003Publication date: May 4, 2006Inventors: Sachiyo Tada, Yasumasa Akai, Yasuyuki Imura, Shigeki Abe, Harumi Minekawa